2020
DOI: 10.1002/cmdc.202000548
|View full text |Cite
|
Sign up to set email alerts
|

Structure‐Activity Relationships of Benzamides and Isoindolines Designed as SARS‐CoV Protease Inhibitors Effective against SARS‐CoV‐2

Abstract: Inhibition of coronavirus (CoV)‐encoded papain‐like cysteine proteases (PLpro) represents an attractive strategy to treat infections by these important human pathogens. Herein we report on structure‐activity relationships (SAR) of the noncovalent active‐site directed inhibitor (R)‐5‐amino‐2‐methyl‐N‐(1‐(naphthalen‐1‐yl)ethyl) benzamide (2 b), which is known to bind into the S3 and S4 pockets of the SARS‐CoV PLpro. Moreover, we report the discovery of isoindolines as a new class of potent PLpro inhibitors. The … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
34
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 42 publications
(35 citation statements)
references
References 28 publications
1
34
0
Order By: Relevance
“…The search for PLpro inhibitors has already begun. So far, most studies focus on trying to utilize previously developed noncovalent SARS-CoV inhibitors or their derivatives [7,24,29] or to design specific, covalent inhibitors [30,31]. However, covalent protease inhibitors come with risks of toxicity due to high reactivity and, in some cases, low selectivity and nonspecific binding off the target [32][33][34].…”
Section: Introductionmentioning
confidence: 99%
“…The search for PLpro inhibitors has already begun. So far, most studies focus on trying to utilize previously developed noncovalent SARS-CoV inhibitors or their derivatives [7,24,29] or to design specific, covalent inhibitors [30,31]. However, covalent protease inhibitors come with risks of toxicity due to high reactivity and, in some cases, low selectivity and nonspecific binding off the target [32][33][34].…”
Section: Introductionmentioning
confidence: 99%
“…In line with our long-term mission to identify pharmacologically relevant protease inhibitors, we tested the inhibitory activity of the two most abundant derivatives, xylacremolides A and B, on various pharmacologically important proteases using an established uorescence-based assay (Table 2). [26][27][28][29] Both rhodesain (Rd), and cruzain, cysteine proteases belonging to the papain-family, play central roles in the life cycle of the parasitic protists Trypanosoma brucei (Human African Trypanosomiasis (HAT)) 30 and Trypanosoma cruzi (Chagas-disease), 31 respectively. Three proteases were selected for their important functions in cancer cells (Cath L, Cath B, urokinase (uPA)).…”
Section: Bioactivities Of Xylacremolide a And Bmentioning
confidence: 99%
“…Protease inhibition assays. [26][27][28][29] Compounds were dissolved in DMSO (20 mM). Fluorometric assays were performed at a concentration of 200 mM.…”
Section: Structure Elucidationmentioning
confidence: 99%
“…1-(Naphthalen-1-yl)ethyl derivatives 190-196 [138][139][140][141][142] (Fig. 21) have been studied in suffi cient detail.…”
Section: Doi: 101134/s107042802105002xmentioning
confidence: 99%